Mechanisms and factors associated with gastrointestinal symptoms in patients with diabetes mellitus

Jornal de Pediatria

Volumn 88, Issue 1, 2012, Pages 17-24

  Rodrigues, Mônica Loureiro Celino ^a   Motta, Maria Eugênia Farias Almeida ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Adolescent; Child; Diabetes mellitus; Digestive signs and symptoms; Etiology; Gastrointestinal motility

Indexed keywords

AUTOANTIBODY; INDOMETACIN; INTERLEUKIN 6; METFORMIN; NEUROTRANSMITTER; PROSTAGLANDIN; SULFONYLUREA DERIVATIVE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACHLORHYDRIA; AGE; ATROPHIC GASTRITIS; AUTOIMMUNITY; CONSTIPATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIARRHEA; DIET THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DYSPEPSIA; DYSPHAGIA; EPIGASTRIC PAIN; EXERCISE; FECES INCONTINENCE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL CELL OF CAJAL; INTESTINAL DYSMOTILITY; INTESTINE INNERVATION; IRRITABLE COLON; LYMPHOCYTIC INFILTRATION; MORBIDITY; NAUSEA; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; STOMACH EMPTYING; STOMACH PARESIS; TACHYGASTRIA; VOMITING;

ADOLESCENT; CHILD; DIABETES COMPLICATIONS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS;

EID: 84857293254     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.2153     Document Type: Review

References (61)

1. Dias AS, Llesuy S, Marroni CA, Marroni N. Alterações gastrointestinais no diabetes mellitus: estresse oxidativo e fluxo sanguíneo da artéria mesentérica - estudo experimental. Arq Gastroenterol. 2004;41:108-13. (Pubitemid 39422979)
2. Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes: tratamento e acompanhamento do diabetes mellitus. Rio de Janeiro: SBD, 2006.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30:S43-7.
4. Libman IM. Epidemiología de la diabetes mellitus en la infancia y adolescencia: tipo 1, tipo 2 y ¿diabetes "double"? Rev Arg Endocrinol Metabol. 2009;46:22-36.
5. Barceló A, Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas. Rev Panam Salud Publica. 2001;10:300-8. (Pubitemid 33143952)
6. Collado-Mesa F, Barceló A, Arheart KL, Messiah SE. An ecological analysis of childhood-onset type 1 diabetes incidence and prevalence in Latin America. Rev Panam Salud Publica. 2004;15:388-94. (Pubitemid 38988997)
7. Catanzariti L, Faulks K, Moon L, Wateus AM, Flack J, Craig ME. Autralian's national trends in the incidence of type 1 diabetes in 0-14 years old, 2000-2006. Diabet Med. 2009;26:596-601.
8. Campos JJ, Almeida HG, Iochida LC, Franco JL. Incidência de diabetes mellitus tipo 1 na cidade de Londrina, PR - Brasil. Arq Bras Endocrinol Metab. 1998;42:36-44.
9. Bittinger M, Barnet J, Wienbeck M. Autonomic dysfunction and the gastrointestinal tract. Clin Auton Res. 1999;9:75-81. (Pubitemid 29462687)
10. Troncon LE, Lopes RP, Simão MN, Iquegami M, Rosa e Silva L, Nobre-e-Souza MA, et al. Frequência de sintomas digestivos em pacientes brasileiros com diabetes mellitus. Rev Ass Med Brasil. 2001;47:157-64.
11. Chucciara S, Borrelli O. Diabetes and gastrointestinal tract: the intrigue continues. J Pediatr Gastroenterol Nutr. 2004;38:4-6. (Pubitemid 39274458)
12. Chandrasekharan B, Anitha M, Blatt R, Shahnavaz N, Kooby D, Staley C, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011;23:131-8.
13. Sierra VA. Manifestaciones gastrointestinales de la diabetes mellitus. Rev Col Gastroenterol. 2006;21:39-56.
14. Mashimo H, May RJ, Goyal RK. Efeitos do diabetes mellitus no sistema digestório. In: Kahn CR, Weir GC, King JL, Jacobson AM, Moses AC, Smith RJ. Diabetes melito. São Paulo: Artmed; 2009. p.1081-114.
15. Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001;15:137-42. (Pubitemid 32055594)
16. Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008;14:709-12. (Pubitemid 351325052)
17. Ebert EC. Gastrointestinal complications of diabetes mellitus. Dis Mon. 2005;51:620-63. (Pubitemid 43183740)
18. Adib S, Rizvi A, Jahan F, Rabbani F, Islam N, Khan MH, et al. Poor glycaemic control is the major factor associated with increased frequency of gastrointestinal symptoms in patients with diabetes mellitus. J Pak Med Assoc. 2007;57:345-9. (Pubitemid 351235466)
19. Koch CA, Uwaifo GI. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur J Gastroenterol Hepatol. 2008;20:822-6.
20. Hasler WL. Type 1 diabetes and gastroparesis: diagnosis and treatment. Cur Gastroenterol Rep. 2007;9:261-9. (Pubitemid 47489985)
21. Quan C, Talley NJ, Jones MF, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol. 2007;20:888-97.
22. Kim JH, Park HS, Ko SY, Hong SN, Sung IK, Shim CS, et al. Diabetes factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol. 2010;16:1782-7.
23. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983;98:378-84. (Pubitemid 13158511)
24. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol. 1989;84:868-72. (Pubitemid 19219758)
25. Burghen GA, Murrell LR, Whitington GL, Klyce MK, Burstein S. Acid peptic disease in children with type 1 diabetes mellitus: a complicating relationship. Am J Dis Child. 1992;146:718-22.
26. Janatuinem E, Pikkarainen P, Laakso M, Pyörälä K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol. 1993;28:427-32. (Pubitemid 23116595)
27. Vazeou A, Papadopoulou A, Booth IW, Bartsocas CS. Prevalence of gastrointestinal symptoms in children and adolescents with type 1 diabetes. Diabetes Care. 2001;24:962-4. (Pubitemid 33636082)
28. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604-11. (Pubitemid 34245887)
29. Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic authonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med. 1990;150:1218-22. (Pubitemid 20188455)
30. Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808-16.
31. Vazeou A, Papadopoulou A, Papadimitriou A, Kitson E, Stathatatos M, Bartsocas CS. Autonomic neuropathy and gastrointestinal motility disorders in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr. 2004;38:61-5. (Pubitemid 39274469)
32. Sobral DT, Vidigal KS, Farias e Silva K. Digestive symptoms in young individuals: survey among medical students. Arq Gastroenterol. 1991;28:27-32.
33. Camillieri M. Gastrointestinal problems in diabetes. Endocrinol Metab Clin North Am. 1996;25:361-78.
34. Agréus L. The epidemiology of functional gastrointestinal disorders. Eur J Surg Suppl. 1998;583:60-6. (Pubitemid 29054910)
35. Ördög T, Hayashi Y, Gibbons SJ. Cellular pathogenesis of diabetic gastroenteropathy. Minerva Gastroenterol Dietol. 2009;55:315-43.
36. Hasler WL, Soudah HC, Dulai G, Owyang C. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gast roenterology. 1995;108:727-36.
37. Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil. 2007;19:951-60. (Pubitemid 350198313)
38. Targher G, Zenari L, Bertolini L, Muggeo M, Zoppini G. Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care. 2001;24:956-7.
39. Jackson MW, Gordon TP, Waterman SA. Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology. 2004;126:819-28.
40. De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, Van Acker KL, Van Gaal LF. Autoimmune gastropathy in type 1 diabetic patients with parietal cells antibodies: histological and clinical findings. Diabetes Care. 2003;26:82-8 (Pubitemid 36928998)
41. World Health Organization, Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes. Geneva: WHO; 1999.
42. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371-81. (Pubitemid 32119141)
43. Sogabe M, Okahisa T, Tsujigami K, Okita Y, Hayashi H, Taniki T et al. Ultrasonographic assessment of gastric motility in diabetic gastroparesis before and after attaining glycemic control. J Gastroenterol. 2005;40:583-90. (Pubitemid 41038787)
44. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol. 2008;103:2023-30.
45. De Block CE, De Leeuw IH, Pelckmans PA, Callens D, Máday E, Van Gaal LF. Delayed gastric emptying and gastric autoimmunity in type 1 diabetes. Diabetes Care. 2002;25:912-7. (Pubitemid 41094292)
46. O'Donovan D, Feinle-Bisset C, Jones K, Horowitz M. Idiopathic and diabetic gastroparesis. Curr Treat Options Gastroenterol. 2003;6:299-309.
47. Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med. 2007;356:820-9.
48. Punkkinen J, Färkkilä M, Mätzke S, Korppi-Tommola T, Sane T, Piirilä P, et al. Upper abdominal symptoms in patients with type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy. Diabet Med. 2007;25:570-7. (Pubitemid 351590890)
49. Foss-Freitas MC, Marques Junior W, Foss MC. Neuropatia autonômica: uma complicação de alto risco no diabetes melito tipo 1. Arq Bras Endocrinol Metabol. 2008;52:398-406.
50. Woerle HJ, Albrecht M, Linke R, Neumann C, Nicolaus M, Gerich JE, et al. Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care. 2008;31:2325-31.
51. Verrotti A, Loiacono G, Mohn A, Chiarelli F. New insights in diabetic autonomic neuropathy in children and adolescents. Eur J Endocrinol. 2009;161:811-8.
52. Cesarini PR, Ferreira SR, Dib SA. Gastroparesia diabética. Rev Assoc Med Brasil. 1997;43:163-8.
53. Camillieri M. Advances in diabetic gastroparesis. Rev Gastroenterol Disord. 2002;2:47-56.
54. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults. Am J Gastroenterol. 2003;98:391-8. (Pubitemid 36232391)
55. Pasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patient with diabetic gastroparesis. BMC Gastroenterol. 2008;8:21.
56. Hebbard GS, Samsom M, Sun WM, Dent J, Horowitz M. Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. Am J Physiol. 1996;271:G814-9.
57. Rayner CK, Verhagen MA, Hebbard GS, DiMatteo AC, Doran SM, Horowitz M. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia. Am J Gastroenterol. 2000;95:1175-83. (Pubitemid 30263509)
58. Howlett HC, Bailey CJ. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Staf. 1999;20:489-503. (Pubitemid 29296595)
59. Araújo LM, Brito MM, Cruz TR. Tratamento do diabetes mellitus do tipo 2: novas opções. Arq Bras Endocrinol Metab. 2000;44:509-18.
60. Florez H, Luo J, Castillo-Florez S, Mitsi G, Hanna J, Tamariz L, et al. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Postgrad Med. 2010;122:112-20.
61. Thomsen RW, Riis AH, Kieldsen S, Schønheyder HC. Impact of diabetes and poor glicaemic control on risk of bacteraemia with haemolitic streptococci groups A, B, and G. J Infect. 2011;63:8-16.